StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries Non-GAAP Gross Profit by Quarter

Non-GAAP Gross Profit ($M)

Teva Pharmaceutical Industries Non-GAAP Gross Profit: $2,580M in Q3 2026, up 4.2% from a year earlier.

Latest, Q3 2026
2,580
Period ended Sep 30, 2026
Change on a year earlier
+4.2%
2,475 in Q3 2025
History
33 quarters
Since Q3 2018
Sources
33
Documents cited below

Where the Q3 2026 figure comes from

“|| Non-GAAP gross profit | $ | 2,580 | 2,475 | $ | 6,981 | 6,807”

Source: Form 8-K Earnings Release (0001171843-26-007054) ↗

Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Gross Profit ($M)Year on yearSource
Q3 2026Sep 30, 20262,580+4.2%Form 8-K Earnings Release (0001171843-26-007054) ↗
Q2 2026Jun 30, 20262,293+0.7%Form 8-K Earnings Release (0001171843-26-004974) ↗
Q1 2026Mar 31, 20262,108+2.6%Form 8-K Earnings Release (0001171843-26-002796) ↗
Q4 2025Dec 31, 20259,647+316.0%Form 8-K Earnings Release (0001171843-26-000462) ↗
Q3 2025Sep 30, 20252,475+6.4%Form 8-K Earnings Release (0001171843-25-007000) ↗
Q2 2025Jun 30, 20252,278+3.3%Form 8-K Earnings Release (0001171843-25-004808) ↗
Q1 2025Mar 31, 20252,054+4.6%Form 8-K Earnings Release (0001171843-25-002849) ↗
Q4 2024Dec 31, 20242,319-72.6%Form 8-K Earnings Release (0001171843-25-000493) ↗
Q3 2024Sep 30, 20242,327+13.0%Form 8-K Earnings Release (0001171843-24-006034) ↗
Q2 2024Jun 30, 20242,205+9.0%Form 8-K Earnings Release (0001171843-24-004270) ↗
Q1 2024Mar 31, 20241,963+9.3%Form 8-K Earnings Release (0001193125-24-133759) ↗
Q4 2023Dec 31, 20238,470+5.1%Form 8-K Earnings Release (0001157523-24-000137) ↗
Q3 2023Sep 30, 20232,060+8.1%Form 8-K Earnings Release (0001157523-23-001677) ↗
Q2 2023Jun 30, 20232,023-1.7%Form 8-K Earnings Release (0001157523-23-001212) ↗
Q1 2023Mar 31, 20231,796-9.6%Form 8-K Earnings Release (0001157523-23-000797) ↗
Q4 2022Dec 31, 20228,056-6.5%Form 8-K Earnings Release (0001157523-23-000205) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Non-GAAP Gross Profit ($M), quarterly Q3 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-gp

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?